Financials Mesa Laboratories, Inc.

Stocks

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 14/08/2026 BST			5-day change	1st Jan Change
106.04 ^USD	-6.33%		+3.30%	+35.08%

08-10	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
08-10	Mesa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Projected Income Statement: Mesa Laboratories, Inc.

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	184.3	219.1	216.2	241	249.1	255.3	270.3
Change	-	18.85%	-1.32%	11.47%	3.38%	2.48%	5.86%
EBITDA ¹	41.16	49.68	50.5	56.74	63.49	62	68.45
Change	-	20.7%	1.66%	12.34%	11.9%	-2.34%	10.4%
EBIT ¹	37.9	45.82	50.5	51.36	58.23	60.5	65.9
Change	-	20.9%	10.22%	1.68%	13.39%	3.89%	8.93%
Interest Paid ¹	-3.885	-4.77	-5.697	-11.86	-10.69	-9.933	-9.1
Earnings before Tax (EBT) ¹	3.574	-0.389	-275.6	5.961	12.01	17.83	28.53
Change	-	-110.88%	-70,760.67%	102.16%	101.54%	48.44%	60%
Net income ¹	1.871	0.93	-254.2	-1.974	6.712	13.27	21.13
Change	-	-50.29%	-27,438.28%	99.22%	440.02%	97.66%	59.3%
Announcement Date	31/05/22	25/05/23	05/06/24	28/05/25	27/05/26	-	-

¹USD in Million

Estimates

Fiscal Period: March	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2	2028 Q3	2028 Q4
Net sales ¹	35.84	54.7	58.88	50.45	58.75	54.29	55.59	50.64	53.16	53.47	58.9	58.17	57.83	62.84	62.14	59.54	60.74	65.13	63.72	60.14	61.63	66.37	67.13	62	65.8	68.5	68.9
Change	-	52.61%	7.65%	-14.31%	16.44%	-7.6%	2.4%	-8.9%	4.98%	0.58%	10.16%	-1.25%	-0.58%	8.66%	-1.12%	-4.17%	2.01%	7.23%	-2.15%	-5.63%	2.49%	7.68%	1.16%	-7.65%	6.13%	4.1%	0.58%
EBITDA ¹	10.52	8.028	12.72	6.972	16.42	14.04	12.25	10.44	11.22	11.98	14.94	16.74	14.35	14.79	12.26	12.9	15.23	17.07	18.28	15.42	13.1	16.55	17.7	15.7	17.1	16.8	17.2
Change	-	-23.67%	58.5%	-45.21%	135.53%	-14.51%	-12.73%	-14.8%	7.48%	6.74%	24.74%	12.1%	-14.29%	3.04%	-17.12%	5.27%	18.07%	12.07%	7.08%	-15.66%	-15.03%	26.34%	6.95%	-11.3%	8.92%	-1.75%	2.38%
EBIT ¹	10.12	13.78	11.65	6.158	15.47	12.86	10.71	9.524	10.31	10.9	14.94	15.34	12.83	13.68	10.9	11.5	13.92	15.8	17.02	14.16	13.4	16.7	14.9	16.2	16.5	16.7	16.5
Change	-	36.23%	-15.44%	-47.16%	151.25%	-16.91%	-16.68%	-11.09%	8.23%	5.75%	37.03%	2.7%	-16.34%	6.61%	-20.32%	5.47%	21.05%	13.54%	7.68%	-16.76%	-5.39%	24.63%	-10.78%	8.72%	1.85%	1.21%	-1.2%
Charge d'intérêts ¹	-0.815	-1.018	-1.238	-1.014	-1.214	-1.162	-1.38	-1.048	-0.905	-1.856	-1.888	-2.842	-3.018	-2.842	-2.519	-2.198	-2.862	-3.036	-2.596	-	-2.467	-2.4	-2.4	-3.7	-3.6	-3.6	-3.6
Earnings before Tax (EBT) ¹	4.543	-2.341	-0.046	-5.412	3.384	1.916	-0.277	-0.937	-1.325	1.946	-275.3	3.905	3.812	-2.217	0.461	7.012	1.999	4.596	-1.593	4.353	2.467	5.7	5.8	4.7	5.3	5.7	5.7
Change	-	-151.53%	98.04%	-11,665.22%	162.53%	-43.38%	-114.46%	-238.27%	-41.41%	246.87%	-14,248.61%	101.42%	-2.38%	-158.16%	120.79%	1,421.04%	-71.49%	129.91%	-134.66%	373.26%	-43.33%	131.08%	1.75%	-18.97%	12.77%	7.55%	0%
Net income ¹	3.72	-2.06	-1.784	-1.438	1.306	0.451	0.611	-0.549	-1.23	2.116	-254.6	3.388	3.428	-1.676	-7.114	4.742	2.476	3.63	-4.136	2.83	1.8	4.3	4.333	3.7	4.2	4.4	4.5
Change	-	-155.38%	13.4%	19.39%	190.82%	-65.47%	35.48%	-189.85%	-124.04%	272.03%	-12,131.33%	101.33%	1.18%	-148.89%	-324.46%	166.66%	-47.79%	46.61%	-213.94%	168.42%	-36.4%	138.89%	0.78%	-14.62%	13.51%	4.76%	2.27%
Announcement Date	04/11/21	03/02/22	31/05/22	04/08/22	03/11/22	06/02/23	25/05/23	03/08/23	06/11/23	05/02/24	05/06/24	05/08/24	07/11/24	04/02/25	28/05/25	05/08/25	06/11/25	03/02/26	27/05/26	10/08/26	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Mesa Laboratories, Inc.

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Net Debt	169	150	-	-	-	-	-
Change	-	-11.24%	-	-	-	-	-
Announcement Date	31/05/22	25/05/23	05/06/24	28/05/25	27/05/26	-	-

Estimates

Cash Flow Forecast: Mesa Laboratories, Inc.

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	4.432	4.544	2.567	4.249	3.25	4.05	4.25
Change	-	2.53%	-43.51%	65.52%	-23.51%	24.62%	4.94%
Free Cash Flow (FCF) ¹	34.79	23.44	41.57	42.56	39.58	44.4	46.7
Change	-	-32.63%	77.34%	2.39%	-7%	12.18%	5.18%
Announcement Date	31/05/22	25/05/23	05/06/24	28/05/25	27/05/26	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Mesa Laboratories, Inc.

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	22.33%	22.68%	23.36%	23.54%	25.48%	24.29%	25.33%
EBIT Margin (%)	20.56%	20.92%	23.36%	21.31%	23.37%	23.7%	24.38%
EBT Margin (%)	1.94%	-0.18%	-127.5%	2.47%	4.82%	6.99%	10.56%
Net margin (%)	1.01%	0.42%	-117.6%	-0.82%	2.69%	5.2%	7.82%
FCF margin (%)	18.87%	10.7%	19.23%	17.66%	15.89%	17.39%	17.28%
FCF / Net Income (%)	1,859.49%	2,520.32%	-16.35%	-2,155.98%	589.71%	334.67%	220.98%
Profitability
ROA	6.69%	6.34%	-	7.51%	10.78%	14.5%	17.1%
ROE	10.94%	11.03%	-	21.65%	26.83%	33.4%	31.9%
Financial Health
Leverage (Debt/EBITDA)	4.11x	3.03x	-	-	-	-	-
Debt / Free cash flow	4.86x	6.42x	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2.4%	2.07%	1.19%	1.76%	1.3%	1.59%	1.57%
CAPEX / EBITDA (%)	10.77%	9.15%	5.08%	7.49%	5.12%	6.53%	6.21%
CAPEX / FCF (%)	12.74%	19.39%	6.18%	9.98%	8.21%	9.12%	9.1%
Items per share
Cash flow per share ¹	7.345	5.22	8.194	8.635	7.696	6.22	6.76
Change	-	-28.94%	56.98%	5.38%	-10.86%	-19.18%	8.68%
Dividend per Share ¹	0.64	0.64	0.64	0.64	0.64	0.64	0.64
Change	-	0%	0%	0%	0%	0%	0%
Book Value Per Share ¹	74.79	73.28	26.95	29.3	33.71	34.96	38.39
Change	-	-2.01%	-63.22%	8.7%	15.06%	3.71%	9.81%
EPS ¹	0.35	0.17	-47.2	-0.36	1.21	2.207	3.34
Change	-	-51.43%	-27,864.71%	99.24%	436.11%	82.37%	51.36%
Nbr of stocks (in thousands)	5,246	5,346	5,394	5,434	5,525	5,596	5,596
Announcement Date	31/05/22	25/05/23	05/06/24	28/05/25	27/05/26	-	-